Background {#sec1-1}
==========

Inflammation is now widely known as an adaptive pathophysiological response underlying various chronic diseases including type 2 diabetes mellitus, cardiovascular disease, obesity, metabolic diseases, and specific types of cancer.\[[@ref1][@ref2][@ref3]\] Several factors are associated with inflammation such as sex, age, and lifestyle. Lifestyle such as diet, physical activity, and smoking as malleable factors can reduce inflammation and thereby contributing to health.

Diet plays a contributing role in the regulation of inflammatory process. Various biomarkers have used to evaluate the association of nutrition and low-grade inflammatory status.\[[@ref4]\] Consequently, it may be beneficial to identify dietary patterns related to their inflammatory properties.\[[@ref5]\] Dietary inflammatory index (DII) is a new approach used to evaluate the inflammatory potential of a diet as either anti-inflammatory or pro-inflammatory.\[[@ref6]\] In fact, some of the dietary patterns such as western pattern diet rich in red meat and refined grains is associated with a higher level of CRP, TNF- α, IL-1β, IL-2, and IL-6, which is often referred to as pro-inflammatory biomarkers. In contrast, there is an inverse association between Mediterranean diet including high amounts of fruits, whole grains, extra-virgin olive oil, and pro-inflammatory status.\[[@ref7][@ref8]\]

Nowadays, the inflammatory properties of diet and its role in preventing chronic diseases have attracted much attention from health sciences researchers. Although in recent years several studies have shown the association of DII and risk of different cancer types, the findings of these studies are heterogeneous according to the type of study and cancer. However, according to our knowledge, pooled estimate of association of DII and all cancers is unclear and have not been investigated yet by systematic review. The aim of this meta-analysis was to investigate the association of DII with risk of incidence and mortality of any cancer types.

Methods {#sec1-2}
=======

To evaluate the maximum level of sensitivity, we simultaneously searched main international electronic data sources; PubMed and NLM Gateway (for MEDLINE), Institute of Scientific Information (ISI), and SCOPUS for studies until January, 2017. Further, a hand-search of all references included in the identified articles. We did not limit our research by the publication date and language.

Our strategy for searching relevant studies was using the following key words "Index-based dietary patterns," "dietary inflammatory Index or DII," and all related domains to neoplasm," "cancer," "Malignancy," and "tumor".

Any observational epidemiologic study, either cross-sectional, case-control, or cohort, which had used DII, and the estimation of a adjusted effect size measure \[odds ratio (OR), relative risk (RR), and hazard ratio (HR)\] and 95% confidence interval (CI) comparing level and score of the DII with respect to the risk of incidence, mortality, and length of hospitalization of all cancer types were eligible to include in this systematic review. We excluded all papers with duplicate entries. In case of multiple publications on the same population, only the largest study or the main source of data was included.

The quality of studies was assessed using the Newcastle-Ottawa scale designing for cohort and case-control studies. According to this scale, 9 points can be allocated to each study including four scores for selection, two scores for comparability, and three scores for assessment of outcomes. The process of quality assessment and data extraction was carried out independently by two research experts. Quality assessment agreement on quality assessment between raters was established using Cohen\'s kappa statistic. The Kappa statistic for agreement on quality assessment was 0.92, which shows perfect agreement. The discrepancy between the raters was resolved by an auditor. Data were extracted according to a checklist. The items on the checklist included (a) the number of citation; (b) demographic characteristics of population such as age, target population, and type of cancers; (c) methodological information of study such as study design, food assessment questionnaire, duration of follow-up, sample size, type of effect size measure (OR, RR, and HR), and adjusted covariates.

Statistical analysis {#sec2-1}
--------------------

We examined the association of DII and cancers in terms of morbidity (incidence), mortality, and length of hospitalization. For meta-analysis, we classified cancers into four main categories: (a) digestive tract cancers; (b) hormone-dependent cancers; (c) respiratory tract cancers; and (d) urothelial cancers. However, for those studies that reported several adjusted models, we included only the multivariate model. Although in this systematic review we included all studies with reported DII as continuous (score) or categorical variable (tertile/quartile/quintile), we performed meta-analysis only for DII as categorical variable. In meta-analysis, risk of incidence and mortality of cancer in the highest level of DII (last tertile/quartile/quintile) was compared with lowest level of DII (last tertile/quartile/quintile). Although a number of studies have reported cancer subsites, meta-analysis have not performed according to subsites of cancer.\[[@ref9][@ref10][@ref11][@ref12][@ref13][@ref14]\] The meta-analysis on the association between DII and risk of cancer mortality has been conducted only for all cancer mortality. Because there was only one study on the association between length of hospitalization and DII, we did perform mate-analysis for the association of DII and length of hospitalization of cancer.

The results reported as adjusted effect size measure and 95% CI. The Chi-square based Q test and I square statistics used to assess the heterogeneity between studies. The results of Q test were statistically significant at *P* \< 0.1. Because of severe heterogeneity among studies on the reported values, pooled estimate was estimated using random-effect meta-analysis model (using the Dersimonian and Laird method). The forest plot also was used to present the results of meta-analysis schematically. A random-effects meta-regression was performed using unrestricted maximum likelihood method to evaluate the association of estimated effect size measure and potential confounders such as design of study, type of cancer, food assessment questionnaire, and publication year. Potential publication bias was assessed using Egger\'s weighted regression tests, and the results of Egger\'s test were statistically significant at *P* \< 0.1. The funnel plot also was used to present the results of publication bias schematically. "Trim and fill" method was used to adjust the analysis for the effects of publication bias. All statistical analysis was performed using STATA 11 software.

Ethical considerations {#sec2-2}
----------------------

The protocol of study was approved by the ethical committee of Alborz University of Medical Science. All reviewed studies were properly cited. For more information about a certain study, we contacted the corresponding authors.

Results {#sec1-3}
=======

The literature search strategy yielded a total of 575 publications. Further, 148 duplicated articles were excluded. After screening titles and abstracts, 345 irrelevant publications were excluded. Then, 82 remained articles and 6 retrieved articles through reference checking were carefully assessed and reviewed for eligibility; of which, 50 studies were excluded according to inclusion criteria. Finally, 38 studies met the inclusion criteria \[[Figure 1](#F1){ref-type="fig"}\]. The main results of the selected articles were discussed in terms of incidence (*n* = 29), mortality (*n* = 7), both of them (*n* = 1), and length of hospitalization (*n* = 1) in patients with different types of cancers.

![Papers search and review flowchart for selection of primary studies](IJPVM-11-15-g001){#F1}

We found 30 articles (i.e. 20 case- controls and 10 cohorts) on the association of DII and incidence of different cancer types \[[Table 1](#T1){ref-type="table"}\]. Twenty-eight articles used food frequency questionnaire (FFQ), and the rest used 24 hour dietary recall (24HR) and dietary history questionnaire as dietary assessment instruments. The highest and lowest effect size measures (95% CI) were observed for esophageal squamous cell carcinoma (OR: 8.24; 95% CI: 2.03-33.47) and breast cancer (HR: 0.85; 95% CI: 0.52-1.41), respectively.

###### 

Association between DII and risk of cancer incidence

  Study number                                             First author (year)                            Design              Follow- -up (years)   Food assessment questionnaire     Type/site of cancer                                                                      Total sample size (incident cases)                       Groups                                                                              Type of effect size measure   Effect size measure (95% CI)                                                           Covariates
  -------------------------------------------------------- ---------------------------------------------- ------------------- --------------------- --------------------------------- ---------------------------------------------------------------------------------------- -------------------------------------------------------- ----------------------------------------------------------------------------------- ----------------------------- -------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1                                                        Samuel O. Antwi (2016)\[[@ref30]\]             Case-control        NA                    144 -item FFQ                     Pancreatic cancer                                                                        2573 (817)                                               Quintile 5 (\>-0.03, 4.47) vs. Quintile 1 (-5.33,-3.07)                             OR                            2.54 (1.87-3.46)                                                                       Age, sex, race, diabetes, BMI, pack-years of smoking, education
  2                                                        Young Ae Cho (2016)\[[@ref9]\]                 Case-control        NA                    106-item semi-quantitative FFQ    Colorectal cancer Colon cancer Proximal colon cancer Distal colon cancer Rectal cancer   2769 (923) 2306 (460) 2011 (165) 2141 (295) 2290 (444)   Tertile 3 (≥2.30) vs. Tertile 1 (\<0.30)                                            OR                            2.16 (1.71-2.73) 2.05 (1.53-2.74) 1.68 (1.08-2.61) 2.28 (1.61-3.21) 2.23 (1.66-3.00)   age, sex, BMI, education, family history of colorectal cancer, physical activity, and total calorie intake
  3-1                                                      Pierre-Antoine Dugue (2016)\[[@ref31]\]        cohort              21.3                  121-item FFQ                      Urothelial cell carcinoma                                                                41514 (379)                                              Quintile 5 vs. Quintile 1\*                                                         HR                            1.24 (0.90-1.70)                                                                       sex, country of birth, smoking, alcohol consumption, body mass index physical activity, education, and socioeconomic status
  3-2                                                      Pierre-Antoine Dugue (2016)\[[@ref31]\]        cohort              21.3                  121-item FFQ                      Urothelial cell carcinoma                                                                41514 (379)                                              Continuous DII (per one unit increment)                                             HR                            1.07 (0.97-1.19)                                                                       sex, country of birth, smoking, alcohol consumption, body mass index physical activity, education, and socio-economic status
  4                                                        Isabell Ge (2015)\[[@ref32]\]                  case-control        NA                    176-items FFQ                     Breast cancer                                                                            8300 (2887)                                              Quintile 5 (1.922, 5.504) vs. Quintile 1 (-4.604, -0.213)                           OR                            1.01 (0.86-1.17)                                                                       age, study region, lifestyle confounders (total physical activity after 50 years, energy intake), breast cancer risk factors (age of menarche, number of pregnancies, breastfeeding history, induction of menopause, first-degree family history of breast cancer, history of benign breast disease, number of mammograms, hormone use)
  5                                                        Laurie Graffouille\`re (2016)^a^\[[@ref33]\]   cohort              12.6                  24 HR                             Breast cancer                                                                            3771 (158)                                               Quartile 4 vs.Quartile 1\*                                                          HR                            0.85 (0.52-1.41)                                                                       Age, sex, intervention group of the initial SU.VI.MAX trial, number of 24-h dietary records, BMI, height, physical activity, smoking status, educational level, energy intake, and family history in addition to menopausal status
  Prostate cancer                                          2771 (123)                                     2.08 (1.06-4.09)                                                                                                                                                                                                                                                                                                                                                                                                                       
  vnon-prostate cancer (other cancers)                     6542 (278)                                     1.34 (0.92-1.95)                                                                                                                                                                                                                                                                                                                                                                                                                       
  All cancers                                              6542 (559)                                     1.23 (0.94-1.62)                                                                                                                                                                                                                                                                                                                                                                                                                       
  6                                                        A. M. Hodge (2016)\[[@ref26]\]                 cohort              18                    121-item FFQ                      Lung cancer                                                                              35,303 (403)                                             Quartile 4 (0.39,4.86) vs. Quartile 1 (-4.91,-2.15)                                 HR                            1.31 (0.91-1.89)                                                                       pack-years, years since quit smoking, smoking status, country of birth, education, BMI, alcohol intake, physical activity, sex, SEIFA quintile, energy (includes an interaction between smoking status and country of birth)
  7                                                        Yunxia Lu (2016)\[[@ref34]\]                   Case-control        NA                    63-item FFQ                       Esophageal squamous cell carcinoma                                                       946 (158)                                                Quartile 4 (≥1.46) vs. Quartile 1 (\<−1.04)                                         OR                            4.35 (2.24-8.43)                                                                       age, sex, energy, education, tobacco smoking, alcohol intake, and physical activity in addition to reflux, and Helicobacter pylori infection (for oesophageal adenocarcinoma and gastroesophageal junctional adenocarcinoma)
  Esophageal adenocarcinoma                                987 (181)                                      3.59 (1.87-6.89)                                                                                                                                                                                                                                                                                                                                                                                                                       
  Gastroesophageal junctional adenocarcinoma               1061 (255)                                     2.04 (1.24-3.36)                                                                                                                                                                                                                                                                                                                                                                                                                       
  Esophageal or gastroesophageal junction adenocarcinoma   1242 (436)                                     2.42 (1.57-3.73)                                                                                                                                                                                                                                                                                                                                                                                                                       
  8                                                        Patrick Maisonneuve (2016)\[[@ref35]\]         Cohort              8.5                   45-item FFQ                       Lung cancer                                                                              4336 (200)                                               Quartile 4 vs.Quartile 1\*                                                          HR                            1.54 (0.93-2.55)                                                                       baseline risk probability (age, sex, smoking duration, smoking intensity, years of smoking cessation, and asbestos exposure) and total energy
  9-1                                                      Lauren C. Peres (2017)\[[@ref36]\]             case-control        NA                    110-item FFQ                      Epithelial ovarian cancer                                                                1155 (493)                                               Quartile 4 (-0.32, 3.19) vs. Quartile 1 (-5.57, -3.64)                              OR                            1.72 (1.18-2.51)                                                                       study design variables, age, and study site, family history of breast or ovarian cancer in a first degree relative, parity, OC use, education, BMI, tubal ligation, menopausal status, smoking status, and endometriosis
  9-2                                                      Lauren C.Peres (2017)\[[@ref36]\]              case-control        NA                    110-item FFQ                      Epithelial ovarian cancer                                                                1155 (493)                                               Continuous DII (per one unit increment)                                             OR                            1.10 (1.03-1.17)                                                                       study design variables, age and study site, family history of breast or ovarian cancer in a first degree relative, parity, OC use, education, BMI, tubal ligation, menopausal status, smoking status, and endometriosis
  10-1                                                     Nitin Shivappa (2016)^a^\[[@ref37]\]           Cohort              25                    121-item FFQ                      Breast cancer                                                                            34700 (2934)                                             Tertile 3 (\> -0.05) vs.Tertile 1 (\<-2.08)                                         HR                            1.11 (1.00-1.22)                                                                       Age, energy and BMI, smoking status, pack-years of smoking, education, HRT use, oral contraceptive use, number of live births, education, age at menarche, age at menopause and history of hysterectomy
  10-2                                                     Nitin Shivappa (2016)^a^\[[@ref37]\]           Cohort              25                    121-item FFQ                      Breast cancer                                                                            34700 (2934)                                             Continuous DII (per one unit increment)                                             HR                            1.01 (0.99-1.04)                                                                       Age, energy and BMI, smoking status, pack-years of smoking, education, HRT use, oral contraceptive use, number of live births, education, age at menarche, age at menopause and history of hysterectomy
  11                                                       Nitin Shivappa (2015)^c^\[[@ref38]\]           case-control        NA                    78-item FFQ                       Prostate cancer                                                                          2754 (1294)                                              Quartile 4 (\>0.49) vs. Quartile 1 (\<-1.98)                                        OR                            1.33 (1.01-1.76)                                                                       Age, study center, BMI, years of education, social class, smoking status, family history of prostate cancer, and total energy intake
  12                                                       Nitin Shivappa (2015)^d^\[[@ref39]\]           case-control        NA                    78-item FFQ                       Pancreatic cancer                                                                        978 (326)                                                Quintile 5 (≥ 1.27) vs.Quintile 1 (\< - 1.28)                                       OR                            2·48 (1.50-4.10)                                                                       Age, sex, study center, year of interview, education, BMI, smoking status, alcohol drinking, and history of diabetes
  13-1                                                     Nitin Shivappa (2016)^f^\[[@ref40]\]           case-control        NA                    78-item FFQ                       Gastric cancer                                                                           777 (230)                                                Quartile 4 (\>1.49) vs. Quartile 1 (≤1.47)                                          OR                            2.35 (1.32-4.20)                                                                       study center, age, education, year of interview, BMI, smoking and total energy intake
  13-2                                                     Nitin Shivappa (2016)^f^\[[@ref40]\]           case-control        NA                    78-item FFQ                       Gastric cancer                                                                           777 (230)                                                Continuous DII (per one unit increment)                                             OR                            1.19 (1.06-1.34)                                                                       study center, age, education, year of interview, BMI, smoking, and total energy intake
  14-1                                                     Nitin Shivappa (2015)^g^\[[@ref41]\]           case-control        NA                    125-item FFQ                      Esophageal squamous cell carcinoma                                                       143 (47)                                                 High (\>1.20) vs. Low (≤120)                                                        OR                            8.24 (2.03-33.47)                                                                      age, energy, sex, BMI, years of education, physical activity, smoking, and gastro-oesophageal reflux
  14-2                                                     Nitin Shivappa (2015)^g^\[[@ref41]\]           case-control        NA                    125-item FFQ                      Esophageal squamous cell carcinoma                                                       143 (47)                                                 Continuous DII (per one unit increment)                                             OR                            3.58 (1.76-7.26)                                                                       age, energy, sex, BMI, years of education, physical activity, smoking, and gastro-oesophageal reflux
  15-1                                                     Nitin Shivappa (2016)^h^\[[@ref42]\]           case-control        NA                    78-item FFQ                       Breast cancer                                                                            5157 (2569)                                              Quintile 5 (1.28, 5.14) vs.Quintile 1 (-6.18,-2.13)                                 OR                            1.75 (1.39-2.21)                                                                       age, study center, and energy intake, education, body mass index, parity, menopausal status, and family history of hormone-related cancers
  15-2                                                     Nitin Shivappa (2016)^h^\[[@ref42]\]           case-control        NA                    78-item FFQ                       Breast cancer                                                                            5157 (2569)                                              Continuous DII (per one unit increment)                                             OR                            1.09 (1.05-1.14)                                                                       age, study center, and energy intake, education, body mass index, parity, menopausal status, and family history of hormone-related cancers
  16-1                                                     Nitin Shivappa (2016)^i^\[[@ref43]\]           case-control        NA                    80-item FFQ                       Bladder Cancer                                                                           1355 (690)                                               Quartile 4 (0.42, 4.58) vs.Quartile 1 (-5.94,-2.41)                                 OR                            1.97 (1.28-3.03)                                                                       age, sex, year of interview, study center, total energy intake, education, and tobacco smoking
  16-2                                                     Nitin Shivappa (2016)^i^\[[@ref43]\]           case-control        NA                    80-item FFQ                       Bladder Cancer                                                                           1355 (690)                                               Continuous DII (per one unit increment)                                             OR                            1.11 (1.03-1.20)                                                                       age, sex, year of interview, study center, total energy intake, education, and tobacco smoking
  17-1                                                     Nitin Shivappa (2016)^j^\[[@ref27]\]           case-control        NA                    78-item FFQ                       ovarian cancer                                                                           3442 (1031)                                              Quartile 4 (\>1.35) vs. Quartile 1 (≤1.63)                                          OR                            1.47 (1.07-2.01)                                                                       age, energy intake, year of interview, study center, education, body mass index, parity, oral contraceptive use, menopausal status, and family history of ovarian and/or breast cancer in first-degree relatives
  17-2                                                     Nitin Shivappa (2016)^j^\[[@ref27]\]           case-control        NA                    78-item FFQ                       Ovarian cancer                                                                           3442 (1031)                                              Continuous DII (per one unit increment)                                             OR                            1.08 (1.02-1.14)                                                                       age, energy intake, year of interview, study center, education, body mass index, parity, oral contraceptive use, menopausal status, and family history of ovarian and/or breast cancer in first-degree relatives
  18-1                                                     Nitin Shivappa (2016)^k^\[[@ref44]\]           case-control        NA                    78-item FFQ                       Laryngeal cancer                                                                         1548 (460)                                               Quartile 4 (0.27, 5.00) vs.Quartile 1 (-5.48,-2.19)                                 OR                            3.30 (2.06-5.28)                                                                       age, sex, center, education, body mass index, tobacco smoking, alcohol consumption, and non-alcohol energy intake
  18-2                                                     Nitin Shivappa (2016)^k^\[[@ref44]\]           case-control        NA                    78-item FFQ                       Laryngeal cancer                                                                         1548 (460)                                               Continuous DII (per one unit increment)                                             OR                            1.27 (1.15, 1.40)                                                                      age, sex, center, education, body mass index, tobacco smoking, alcohol consumption, and non-alcohol energy intake
  19-1                                                     Nitin Shivappa (2016)^l^\[[@ref45]\]           case-control        NA                    78-item FFQ                       Nasopharyngeal cancer                                                                    792 (198)                                                Tertile 3 (men: \>0.59; women: \>−0.19) vs. Tertile1 (men: ≤−0.64; women: ≤−1.06)   OR                            1.64 (1.06-2.55)                                                                       place of living, sex, age, year of interview, education, smoking, alcohol drinking, and energy intake according to the residual method
  19-2                                                     Nitin Shivappa (2016)^l^\[[@ref45]\]           case-control        NA                    78-item FFQ                       Nasopharyngeal cancer                                                                    792 (198)                                                Continuous DII (per one unit increment)                                             OR                            1.19 (1.05, 1.36)                                                                      place of living, sex, age, year of interview, education, smoking, alcohol drinking, and energy intake according to the residual method
  20-1                                                     Nitin Shivappa (2016)^m^\[[@ref46]\]           case-control        NA                    78-item FFQ                       Endometrial cancer                                                                       1362 (454)                                               Quartile 4 ( \>1·04) vs. Quartile 1 (\<−1·07)                                       OR                            1·46 (1·02-2·11)                                                                       age, energy, year of interview, education, BMI, age at menarche, menopausal status and age at menopause, parity, history of diabetes, family history of cancers, oral contraceptive use and hormone replacement therapy use
  20-2                                                     Nitin Shivappa (2016)^m^\[[@ref46]\]           case-control        NA                    78-item FFQ                       Endometrial cancer                                                                       1362 (454)                                               Continuous DII (per one unit increment)                                             OR                            1.07 (0.98-1.17)                                                                       age, energy, year of interview, education, BMI, age at menarche, menopausal status and age at menopause, parity, history of diabetes, family history of cancers, oral contraceptive use and hormone replacement therapy use
  21-1                                                     Nitin Shivappa (2015)^n^\[[@ref47]\]           case-control        NA                    21-item FFQ                       Prostate cancer                                                                          479 (229)                                                Quartile 4 vs. Quartile 1\*                                                         OR                            2.39 (1.14-5.04)                                                                       age, BMI, smoking status, education, physical activity, energy intake, family history of prostate cancer
  21-2                                                     Nitin Shivappa (2015)^n^\[[@ref47]\]           case-control        NA                    21-item FFQ                       Prostate cancer                                                                          479 (229)                                                Continuous DII (per one unit increment)                                             OR                            1.27 (0.98-1.50)                                                                       age, BMI, smoking status, education, physical activity, energy intake, and family history of prostate cancer
  22-1                                                     Nitin Shivappa (2014)^o^\[[@ref10]\]           Cohort              19.6±7.0              121-item FFQ                      Colorectal cancer                                                                        34703 (1636)                                             Quintile 5 (\>1.10) vs. Quintile 1 (\<-2.75)                                        HR                            1.20 (1.01-1.43)                                                                       age, BMI, smoking status, pack-years of smoking, HRT use, education, diabetes, and total energy intake
  Colon cancer                                             34703 (1329)                                   1.19 (0.98-1.45)                                                                                                                                                                                                                                                                                                                                                                                                                       
  Rectal cancer                                            34703 (325)                                    1.21 (0.81-1.79)                                                                                                                                                                                                                                                                                                                                                                                                                       
  22-2                                                     Nitin Shivappa (2014)^o^\[[@ref10]\]           Cohort              19.6±7.0              121-item FFQ                      Colorectal cancer                                                                        34703 (1636)                                             Continuous DII (per one unit increment)                                             HR                            1.07 (1.01-1.13)                                                                       age, BMI, smoking status, pack-years of smoking, HRT use, education, diabetes, and total energy intake
  Colon cancer                                             34703 (1329)                                   1.05 (0.99-1.12)                                                                                                                                                                                                                                                                                                                                                                                                                       
  Rectal cancer                                            34703 (325)                                    1.11 (0.98-1.25)                                                                                                                                                                                                                                                                                                                                                                                                                       
  23-1                                                     Nitin Shivappa (2015)^p^\[[@ref48]\]           Cohort              20                    80-item FFQ                       Breast cancer                                                                            45257 (1895)                                             Quartile 4 (\>3.77) vs. Quartile 1 (\<1.87)                                         HR                            1.18 (1.00-1.39)                                                                       age, energy, age at first birth and number of children, age at menarche, BMI, height, multivitamin use, education, smoking status, oral contraceptive use, and family history of breast cancer in the model
  23-2                                                     Nitin Shivappa (2015)^p^\[[@ref48]\]           Cohort              20                    80-item FFQ                       Breast cancer                                                                            45257 (1895)                                             Continuous DII (per one unit increment)                                             HR                            1.04 (1.01-1.09)                                                                       age, energy, age at first birth and number of children, age at menarche, BMI, height, multivitamin use, education, smoking status, oral contraceptive use, and family history of breast cancer in the model
  24-1                                                     Nitin Shivappa (2015)^r^ \[[@ref11]\]          case-control        NA                    78-item FFQ                       Colorectal cancer                                                                        6107 (1953)                                              Quintile 5 (\>1.22) vs. Quintile 1 (≤ -1·05)                                        OR                            1.55 (1.29-1.85)                                                                       age, sex, study center, education, BMI, alcohol drinking, physical activity, and history of colorectal cancer and energy intake (using the residual method)
  Colon cancer                                             5379 (1225)                                    1·39 (1.13-1.71)                                                                                                                                                                                                                                                                                                                                                                                                                       
  Rectal cancer                                            4882 (728)                                     1·47 (1.14-1.90)                                                                                                                                                                                                                                                                                                                                                                                                                       
  24-2                                                     Nitin Shivappa (2015)^r^ \[[@ref11]\]          Case-control        NA                    78-item FFQ                       Colorectal cancer                                                                        6107 (1953)                                              Continuous DII (per one unit increment)                                             OR                            1·13 (1·09-1·18)                                                                       age, sex, study center, education, BMI, alcohol drinking, physical activity, and history of colorectal cancer and energy intake (using the residual method)
  Colon cancer                                             5379 (1225)                                    1·09 (1·04, 1·14)                                                                                                                                                                                                                                                                                                                                                                                                                      
  Rectal cancer                                            4882 (728)                                     1·12 (1·06, 1·19)                                                                                                                                                                                                                                                                                                                                                                                                                      
  25-1                                                     Nitin Shivappa (2015)^s^ \[[@ref49]\]          Case-control        NA                    78-item FFQ                       Esophageal squamous cell cancer                                                          1047 (304)                                               Quintile 5 (\>1.28) vs. Quintile 1 (\<-1.20)                                        OR                            2.47 (1.40-4.36)                                                                       age, sex, year of interview, and area of residence and adjusted for education, alcohol drinking, tobacco smoking, BMI, physical activity, aspirin use, and energy (using the residual method)
  25-2                                                     Nitin Shivappa (2015)^s^ \[[@ref49]\]          Case-control        NA                    78-item FFQ                       Esophageal squamous cell cancer                                                          1047 (304)                                               Continuous DII ( per one unit increment)                                            OR                            1.23 (1.10-1.38)                                                                       age, sex, year of interview, and area of residence and adjusted for education, alcohol drinking, tobacco smoking, BMI, physical activity, aspirin use, and energy (using the residual method)
  26                                                       Fred K Tabung (2016)^a^ \[[@ref50]\]           Cohort              16.02                 122-item FFQ                      Breast cancer                                                                            122788 (7495)                                            Quintile 5 (1.898,5.519) vs. Quintile 1 (-7.055,\< -3.142)                          HR                            0.99 (0.91-1.07)                                                                       age, energy intake, race/ethnicity, income, education, smoking status, mammography within 2 years of baseline, age at menarche, number of live births, oophorectomy status, hormone therapy use, nonsteroidal anti-inflammatory drug (NSAID) use, dietary modification trial arm, hormone therapy trial arm, body mass index, and physical activity
  27                                                       Fred K Tabung (2015)^b^ \[[@ref12]\]           Cohort              11.3                  122-item FFQ                      Colorectal cancer                                                                        152,536 (1920)                                           Quintile 5 (1.953, 5.636) vs. Quintile 1 (-7.055, \< -3.136)                        HR                            1.22 (1.05-1.43)                                                                       
  Colon cancer                                             152,536 (1559)                                 1.23 (1.03-1.46)                                                                                                                                                                                                                                                                                                                                                                                                                       
  Proximal colon cancer                                    152,536 (1034)                                 1.35 (1.09-1.67)                                                                                                                                                                                                                                                                                                                                                                                                                       
  Distal colon cancer                                      152,536 (428)                                  0.84 (0.61-1.18)                                                                                                                                                                                                                                                                                                                                                                                                                       
  Rectal cancer                                            152,536 (361)                                  1.20 (0.84-1.72)                                                                                                                                                                                                                                                                                                                                                                                                                       
  28-1                                                     Ruth A. Vázquez-Salas (2016)\[[@ref51]\]       Case-control        NA                    127-item semi-quantitative FFQ    Prostate cancer                                                                          1188 (394)                                               Tertile 1 (ref) (\<−0·12) vs. Tertile 3 (≥1·28) Continuous DII (per...)             OR                            1.18 (0.85-1.63)                                                                       age, educational level, history of PC in first-degree relatives, BMI 2 years before the interview, physical activity throughout life, smoking status 5 years before the interview,history of chronic diseases
  28-2                                                     Ruth A. Vázquez-Salas (2016)\[[@ref51]\]       Case-control        NA                    127-itemsemi - quantitative FFQ   Prostate cancer                                                                          1188 (394)                                               Continuous DII (per one unit increment)                                             OR                            1·02 (0·94, 1·11)                                                                      age, educational level, history of PC in first-degree relatives, BMI 2 years before the interview, physical activity throughout life, smoking status 5 years before the interview, history of chronic diseases
  29-1                                                     Michael D. Wirth (2015)\[[@ref13]\]            Cohort              9.1±2.9               124-item FFQ                      Colorectal cancer                                                                        489,442 (6225)                                           Quartile 4 (3.25, 6.97) vs. Quartile 1 ( -7.33,-0.59)                               HR                            1.40 (1.28-1.53)                                                                       age, smoking status, BMI, self-reported diabetes, and energy intake - for 1:physical activity, marital status, education and age (STRATA statement) - for 2:age (STRATA statement) - For 3:race and age - For 4:marital status, education, perceived health, census-based income and age (STRATA statement) - for 5:self-reported polyps, education, age and census-based income
  Ascending/Cecum                                          489,442 (2060)                                 1.27 (1.09-1.49)                                                                                                                                                                                                                                                                                                                                                                                                                       
  Transverse/Hepatic and Splenic Flexure                   489,442 (802)                                  1.58 (1.23-2.03)                                                                                                                                                                                                                                                                                                                                                                                                                       
  Descending/Sigmoid                                       489,442 (1614)                                 1.61 (1.35-1.91)                                                                                                                                                                                                                                                                                                                                                                                                                       
  Rectum/Recto sigmoid                                     489,442 (1680)                                 1.45 (1.22-1.73)                                                                                                                                                                                                                                                                                                                                                                                                                       
  29-2                                                     Michael D. Wirth (2015)\[[@ref13]\]            Cohort              9.1±2.9               124-item FFQ                      Colorectal cancer                                                                        489,442 (6225)                                           Continuous DII ( per one unit increment)                                            HR                            1.06 (1.05-1.08)                                                                       age, smoking status, BMI, self-reported diabetes, and energy intake - for 1:physical activity, marital status, education and age (STRATA statement) - for 2:age (STRATA statement) - For 3:race and age - For 4:marital status, education, perceived health, census-based income and age (STRATA statement) -for 5:self-reported polyps, education, age and census-based income
  Ascending/Cecum                                          489,442 (2060)                                 1.05 (1.02-1.07)                                                                                                                                                                                                                                                                                                                                                                                                                       
  Transverse/Hepatic and Splenic Flexure                   489,442 (802)                                  1.06 (1.02-1.10)                                                                                                                                                                                                                                                                                                                                                                                                                       
  Descending/Sigmoid                                       489,442 (1614)                                 1.08 (1.05-1.11)                                                                                                                                                                                                                                                                                                                                                                                                                       
  Rectum/Recto sigmoid                                     489,442 (1680)                                 1.08 (1.05-1.10)                                                                                                                                                                                                                                                                                                                                                                                                                       
  30-1                                                     Raul Zamora-Ros (2015)\[[@ref14]\]             Case-control        NA                    dietary history questionnaire     Colorectal cancer                                                                        825 (424)                                                Quartile 4 (\>3.05) vs. Quartile 1 (\<-0.73)                                        OR                            1.65 (1.05-2.60)                                                                       sex, age, total energy intake, BMI, first-degree family history of colorectal cancer, physical activity, tobacco consumption, and medication use (aspirin and non-steroidal anti-inflammatory drug)
  Colon cancer                                             666 (265)                                      2.24 (1.33-3.77)                                                                                                                                                                                                                                                                                                                                                                                                                       
  Rectal cancer                                            560 (159)                                      1.12 (0.61-2.06)                                                                                                                                                                                                                                                                                                                                                                                                                       
  30-2                                                     Raul Zamora-Ros (2015)\[[@ref14]\]             Case-control        NA                    dietary history questionnaire     Colorectal cancer                                                                        825 (424)                                                Continuous DII ( per one unit increment)                                            OR                            1.08 (1.01-1.15)                                                                       sex, age, total energy intake, BMI, first-degree family history of colorectal cancer, physical activity, tobacco consumption, and medication use (aspirin and non-steroidal anti-inflammatory drug
  Colon cancer                                             666 (265)                                      1.12 (1.04-1.21)                                                                                                                                                                                                                                                                                                                                                                                                                       
  Rectal cancer                                            560 (159)                                      1.03 (0.95-1.12)                                                                                                                                                                                                                                                                                                                                                                                                                       

Abbreviation: FFQ: food frequency questionnaire, 24HR: 24 hour recall, HR: hazard ratio, OR: odds ratio; DII: dietary inflammatory index; NA: not applicable

[Table 2](#T2){ref-type="table"} summarizes 8 cohort studies on the association of DII and mortality of different cancer types. Dietary intake was measured using FFQ and 24HR in the five and three articles, respectively.

###### 

Association of DII and risk of cancer mortality

  Study number                       First author (year)                            design              Follow up (years)             Food assessment questionnaire      Study subjects                        Type of cancer mortality   Total sample size (death number)   Groups                                                            Type of effect size measure   Effect size measure (95% CI)   Covariates
  ---------------------------------- ---------------------------------------------- ------------------- ----------------------------- ---------------------------------- ------------------------------------- -------------------------- ---------------------------------- ----------------------------------------------------------------- ----------------------------- ------------------------------ -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1-1                                Fang Emily Deng (2016)\[[@ref52]\]             cohort              135 and 168 person - months   24 HR                              Normal                                Allcancers                 9631 (385)                         Tertile 1 (ref) (\<−0.20) vs. Tertile 3 (\>2.0)                   HR                            1.23 (0.84-1.79)               age, sex, race, HgbA1C, current smoking,physical activity, BMI, SBP
  Lung cancer                        9631 (99)                                      1.4 (0.79-2.47)                                                                                                                                                                                                                                                                                                         
  Digestive-tract cancer             9631 (99)                                      1.38 (0.69-2.76)                                                                                                                                                                                                                                                                                                        
  1-2                                Fang Emily Deng (2016)\[[@ref52]\]             cohort              135 and 168 person - months   24 HR                              Pre - diabetic                        All cancers                2681 (208)                         Tertile 1 (ref) (\<−0.20) vs. Tertile 3 (\>2.0)                   HR                            2.02 (1.27-3.21)               age, sex, race, HgbA1C, current smoking, physical activity, BMI, SBP
  Lung cancer                        2681 (66)                                      2.01 (0.93-4.34)                                                                                                                                                                                                                                                                                                        
  Digestive-tract cancer             2681 (50)                                      2.89 (1.08-7.71)                                                                                                                                                                                                                                                                                                        
  1-3                                Fang Emily Deng (2016)\[[@ref52]\]             cohort              135 and 168 person - months   24 HR                              Diabetic                              All cancers                968 (83)                           Tertile 1 (ref) (\<−0.20) vs. Tertile 3 (\>2.0)                   HR                            1.00 (0.49-2.04)               age, sex, race, HgbA1C, current smoking, physical activity, BMI, SBP
  Lung cancer                        968 (27)                                       0.55 (0.09-3.36)                                                                                                                                                                                                                                                                                                        
  Digestive-tract cancer             968 (27)                                       1.30 (0.40-4.28)                                                                                                                                                                                                                                                                                                        
  2-1                                Aleksander Galas (2014)^a^\[[@ref53]\]         cohort              3,180.31 person - years       148 item semi - quantitative FFQ   Patients without distant metastases   Colorectal cancer          511 (150)                          High (\>- 2.27) vs. low (≤ -2.27)                                 HR                            0.76 (0.55-1.08)               Age, smoking, marital status, overweight or obesity, calendar year when surgery was performed, surgery type, cancer site, chemotherapy after surgery, radiotherapy after surgery
  Patients with distant metastases   178 (159)                                      1.06 (0.76-1.48)                                                                                                                                                                                                                                                                                                        
  2-2                                Aleksander Galas (2014)^a^\[[@ref53]\]         cohort              3,180.31 person - years       148 itemsemi - quantitative FFQ    Patients without distant metastases   Colorectal cancer          511 (150)                          Continuous DII (per one unit increment)                           HR                            0.98 (0.92-1.05)               Age, smoking, marital status, overweight or obesity, calendar year when surgery was performed, surgery type, cancer site, chemotherapy after surgery, radiotherapy after surgery
  Patients with distant metastases   178 (159)                                      1.003 (0.93-1.08)                                                                                                                                                                                                                                                                                                       
  3-1                                Laurie Graffouille\`re (2016)^b^\[[@ref54]\]   cohort              12.4                          24 HR                              Healthy subjects                      All cancers                7994 (123)                         Tertile 3 vs. Tertile 1\*                                         HR                            1.83 (1.12-2.99)               Age, sex, intervention group of the initial SU.VI.MAX trial, number of 24-h dietary records, BMI, physical activity, smoking status, educational level, family history of cancer in first-degree relatives, family history of CVD in first-degree relatives, energy intake without alcohol, and alcohol intake
  3-2                                Laurie Graffouille\`re (2016)^b^\[[@ref54]\]   cohort              12.4                          24 HR                              Healthy subjects                      All cancers                7994 (123)                         Continuous DII (per one unit increment)                           HR                            1.18 (1.04-1.34)               age, sex, intervention group of the initial SU.VI.MAX trial, number of 24-h dietary records, BMI, physical activity, smoking status, educational level, family history of cancer in first-degree relatives, family history of CVD in first-degree relatives, energy intake without alcohol, and alcohol intake
  4-1                                Nitin Shivappa (2016)^b^\[[@ref55]\]           Cohort              25                            121-item FFQ                       postmeno-pausal women                 All cancers                37525 (5044)                       Quartile 4 (0.6469 to 4.6598) vs. Quartile 1(−5.7509 to−2.5041)   HR                            1.08 (0.99-1.18)               age, BMI, smoking status, pack-years of smoking, HRT use, education, prevalent diabetes, prevalent hypertension, prevalent heart disease, prevalent cancer, total energy intake
  Digestive tract cancers            37525 (1240)                                   1.19 (1.00-1.43)                                                                                                                                                                                                                                                                                                        
  4-2                                Nitin Shivappa (2016)^b^\[[@ref55]\]           Cohort              25                            121-item FFQ                       postmeno-pausal women                 All cancers                37525 (5044)                       Continuous DII (per one unit increment)                           HR                            1.04 (1.01-1.07)               age, BMI, smoking status, pack-years of smoking, HRT use, education, prevalent diabetes, prevalent hypertension, prevalent heart disease,prevalent cancer, total energy intake
  Digestive tract cancers            37525 (1240)                                   1.07 (1.01-1.14)                                                                                                                                                                                                                                                                                                        
  5-1                                Nitin Shivappa (2016)^e^\[[@ref56]\]           Cohort              15                            96-item FFQ                        Healthy women                         All cancers                33747 (1996)                       Quintile 5 (\> 5.10) vs. Quintile 1 (\<−4.19)                     HR                            1.25 (0.96-1.64)               Age, energy, BMI, education, smoking status, physical activity, alcohol intake
  Digestive tract cancers            33747 (602)                                    1.42 (0.82-2.49)                                                                                                                                                                                                                                                                                                        
  5-2                                Nitin Shivappa (2016)^e^\[[@ref56]\]           Cohort              15                            96-item FFQ                        Healthy women                         All cancers                33747 (1996)                       Continuous DII (per one unit increment)                           HR                            1.04 (0.99-1.11)               Age, energy, BMI, education, smoking status, physical activity, alcohol intake
  Digestive cancer                   33747 (602)                                    1.15 (1.02-1.29)                                                                                                                                                                                                                                                                                                        
  6-1                                Nitin Shivappa (2015)^q^\[[@ref57]\]           Cohort              13.5±4.0                      24 HR                              Healthy subjects                      All cancers                12366 (615)                        Tertile 3 (2.03 to 4.83) vs. Tertile 1 (−5.60 to−0.22)            HR                            1.46 (1.10-1.96)               age, sex, race, diabetes status, hypertension, physical activity, BMI, poverty index, and smoking
  Digestive tract cancers            12,366 (158)                                                                                                                                                                                                                                                                                                                                                           
  2.10 (1.15-3.84)                                                                                                                                                                                                                                                                                                                                                                                          
  6-2                                Nitin Shivappa (2015)^q^\[[@ref57]\]           Cohort              13.5±4.0                      24 HR                              Healthy subjects                      All cancers                12,366 (615)                       Continuous DII (per one unit increment)                           HR                            1.04 (0.97-1.11)               age, sex, race, diabetes status, hypertension, physical activity, BMI, poverty index, and smoking
  Digestive tract cancers                                                                                                                                                                                                                                                                                                                                                                                   
  12,366 (158)                       1.08 (0.95-1.22)                                                                                                                                                                                                                                                                                                                                                       
  7                                  Fred K Tabung (2016) ^a^\[[@ref50]\]           Cohort              16.02                         122-item FFQ                       Postmeno-pausal women                 Breast cancer              122788 (667)                       Quintile 5 (1.874 to 5.519) vs. Quintile 1 (−7.055 to \<−3.162)   HR                            1.33 (1.01-1.76)               age, energy intake, race/ethnicity, income, education, smoking status, mammography within 2 years of baseline, age at menarche, number of live births, oophorectomy status, hormone therapy use, nonsteroidal anti-inflammatory drug (NSAID) use, dietary modification trial arm, hormone therapy trial arm, body mass index, and physical activity
  8                                  Antonella Zucchetto (2016)\[[@ref58]\]         Cohort              12.7                          78-item FFQ                        Patients with prostate cancer         Prostate cancer            726 (76)                           Tertile 3 vs. Tertile 1\*                                         HR                            1.42 (0.73-2.76)               area of residence, calendar period of diagnosis, age at diagnosis, education, smoking habits, abdominal obesity, alcohol intake, energy intake

FFQ: Food frequency questionnaire, 24HR: 24 hour recall, HR: Hazard ratio, DII: Dietary inflammatory index

We found only one cohort study [Table 3](#T3){ref-type="table"} on the association between DII and length of hospitalization. There was no significant association exists between DII and length of hospitalization in surgical patients treated for colorectal cancer.

###### 

Association between DII and length of hospitalization

  Study number                                                  First author (year)                      design   Follow up (years)   Food assessment questionnaire     Study subjects                                    Type of cancer mortality   Total sample size (death number)   Groups                                                      Type of effect size measure   Effect size measure (95% CI)   Covariates
  ------------------------------------------------------------- ---------------------------------------- -------- ------------------- --------------------------------- ------------------------------------------------- -------------------------- ---------------------------------- ----------------------------------------------------------- ----------------------------- ------------------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1                                                             Aleksander Galas (2014)^b\[[@ref59]\]^   Cohort   11 days             148 itemsemi - quantitative FFQ   Surgical patients treated for colorectal cancer   Colorectal cancer          689                                Over the first tertile (\> -3.41) vs. tertile 1 (≤ -3.41)   OR                            0.76 (0.53-1.09)               Age, smoking, marital status, overweight or obesity, calendar year when surgery was performed, surgery type, cancer site, chemotherapy after surgery, radiotherapy after surgery
  Over the first quartile (\> -3.91) vs. quartile 1 (≤ -3.91)   0.69 (0.46-1.03)                                                                                                                                                                                                                                                                                                                                 
  Over the first quintile (\> -4.25) vs. quintile 1 (≤ -4.25)   0.69 (0.45-1.07)                                                                                                                                                                                                                                                                                                                                 

FFQ: Food frequency questionnaire, OR: Odds ratio

[Table 4](#T4){ref-type="table"} presents the results of meta-analysis for the association of DII and incidence and mortality of different cancer types. There is a significant association between DII and incidence for all cancer types (OR: 1.32; 95% CI: 1.22-1.42; *P* \< 0.001). A stratified meta-analysis by types of cancer shows that the highest and lowest effect size measures were observed for respiratory tract cancers and hormone-dependent cancers, respectively (OR: 1.64; 95% CI: 1.10-2.17 vs. OR: 1.14; 95% CI: 1.04-1.24). A stratified meta-analysis according to study design shows that the association of DII and incidence of all cancer types in case-control studies (OR: 1.53; 95% CI: 1.36-1.71) were more prominent than cohort studies (OR: 1.18; 95% CI: 1.07-1.30). Figures [2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"} report the forest plot of association between DII and cancer incidence according to the design of study and type of cancers, respectively. Moreover, there is a significant association between DII and mortality for all cancer types (HR: 1.16; 95% CI: 1.01-1.32) \[[Figure 4](#F4){ref-type="fig"}\].

###### 

Meta-analysis of association between DII and mortality/morbidity of cancer

  Type of outcome (Mortality/morbidity)   subgroup         Type of cancer            Number of studies   Test of association   Test of heterogeneity                                             
  --------------------------------------- ---------------- ------------------------- ------------------- --------------------- ----------------------- ---------- -------- ---------- ---------- ----------
  Morbidity                               Type of cancer   Digestive tract cancers   14                  1.55                  1.33-1.78               \< 0.001   Random   81.8       71.27      \< 0.001
  Hormone-dependent cancers               13               1.14                      1.04-1.24           \< 0.001              Random                  59.6       29.72    0.003                 
  Respiratory tract cancers               4                1.64                      1.11-2.17           \< 0.001              Fixed                   45.5       5.51     0.13                  
  Urothelial cancers                      2                1.36                      1.00-1.73           \< 0.001              Fixed                   54.8       2.21     0.13                  
  Type of study                           Case-control     22                        1.53                1.36-1.71             \< 0.001                Random     77.3     92.51      \< 0.001   
  Cohort                                  12               1.18                      1.07-1.30           \< 0.001              Random                  70.1       36.81    \< 0.001              
  Overall                                 34\*             1.32                      1.22-1.42           \< 0.001              Random                  74.5       129.39   \< 0.001              
  Mortality                               All cancers      11                        1.16                1.01-1.32             \< 0.001                Random     44.3     17.96      0.056      

\*The sum of number of studies for all cancers (34 studies) is more than the sum of digestive, hormone-dependent, respiratory and urothelial cancers because in one study, type of cancer was not reported

![Odds ratio and 95% CI of individual studies and pooled data for the association between DII and incidence of cancer according to the type of study using random-effect model. OR: Odds of ratios](IJPVM-11-15-g002){#F2}

![Odds ratio and 95% CI of individual studies and pooled data for the association between DII and incidence of cancer according to the type of cancer using random-effect model. OR: Odds of ratios](IJPVM-11-15-g003){#F3}

![Odds ratio and 95% CI of individual studies and pooled data for the association between DII and mortality of cancer according to the type of cancer using random-effect model. OR: Odds of ratios](IJPVM-11-15-g004){#F4}

Meta-regression {#sec2-3}
---------------

A meta-regression analysis suggests that design of study can have a significant effect on the association between DII and cancer incidence (slope: 0.54; *P* = 0.05), whereas meta-regression does not show any significant associations between DII and type of food assessment questionnaire (slope:-0.33;p = 0.21), type of cancer (slope:-0.22; *P* = 0.22), and publication year (slope: 0.24;p = 0.31). The result of meta-regression analysis for the association of DII and cancer mortality shows no significant association between DII and type of food assessment questionnaire (slope: 0.43; *P* = 0.47), type of cancer (slope:-0.54; *P* = 0.81), and publication year (slope: 0.21; *P* = 0.59).

Publication bias {#sec2-4}
----------------

The results of Egger test for association of DII and all cancer incidence show that publication bias exists (coefficient: 2.87; *P* \< 0.001) and funnel plot was asymmetric \[[Figure 5](#F5){ref-type="fig"}\]. "Trim and fill" correction suggested some potentially missing study on the right side of funnel plot \[[Figure 5](#F5){ref-type="fig"}\]. Imputation for this potentially missing study yielded an effect size of 1.23 (95% CI: 1.12-1.33). In addition, the results of Egger test for association between DII and all cancer mortality show that publication bias does not exist (coefficient: 1.06; *P* = 0.15) and funnel plot was symmetric \[[Figure 6](#F6){ref-type="fig"}\].

![Funnel plot detailing publication bias in the studies reporting the association between DII and all cancer morbidity](IJPVM-11-15-g005){#F5}

![Funnel plot detailing publication bias in the studies reporting the association between DII and cancer mortality](IJPVM-11-15-g006){#F6}

Discussion {#sec1-4}
==========

To the best of our knowledge, the present study is the first comprehensive systematic review and meta-analysis on the association of DII and cancer incidence and mortality. This meta-analysis shows a significant association between DII and risk of incidence and mortality of all cancer types. The results of the present study shows that a higher level of DII increases the risk of cancers incidence by 32% (95% CI: 1.22-1.42) including digestive tract cancers (OR: 1.55; 95% CI: 1.33-1.78), hormone-dependent cancers (OR = 1.14; 95% CI: 1.04-1.24), respiratory tract cancers (OR: 1.64; 95% CI: 1.11-2.17), and urothelial cancers (OR: 1.36; 95% CI: 1.00-1.73). Moreover, a higher level of DII in association with a higher risk of mortality caused by all type of cancer by 16% (95% CI: 1.01-1.32).

Our findings were consistent with previous studies showing that a higher DII was associated with mortality. Moreover, some studies have documented a direct association between DII and a higher risk for metabolic syndrome and cardiovascular diseases (CVD).\[[@ref4]\] One of the study reported different mechanisms by which inflammatory markers used for DII calculation can predict most prevalent diseases including cancers, CVD, and diabetes.\[[@ref6]\]

Results of present study show that the association of DII and incidence of all cancer types in case-control studies were more prominent than cohort studies, which was consistent with previous studies.\[[@ref15][@ref16]\] It has been suggested that dietary recall bias may justify the discrepant results between case-control and cohort studies on diet and the risk of cancers.

Dietary patterns analysis is one of the most appropriate approaches to understand the relationship between diet and risk for various diseases including diabetes, cancers, and CVD.\[[@ref17]\] All of the healthy dietary patterns (e.g. Dietary Approaches to Stop Hypertension and Mediterranean diet) can play a key role in preventing major chronic diseases, especially cancers.\[[@ref18][@ref19][@ref20]\] In contrast, there was an inverse relationship between DII and dietary quality indices (e.g. Healthy Eating Index).\[[@ref21]\] This was in line with the number of studies showing an inverse correlation between C-reactive protein, one of the inflammatory biomarkers used to calculate the DII, and higher consumption of vegetables, fruits,\[[@ref22]\] legumes,\[[@ref23]\] and nuts.\[[@ref24]\]

To define the inflammatory capacity of diet as a main determining factor for vast majority of chronic diseases, we developed DII from peer-reviewed literature by investigating the association between dietary components and inflammation. However, in contrast to the other dietary patterns, DII focuses on specific biological pathways modulating the impact of dietary factors on inflammation.\[[@ref21]\] In fact, in comparison to other dietary pattern, DII can provide more comprehensive information on additional variables affecting inflammation.\[[@ref25][@ref26][@ref27][@ref28][@ref29]\]

The present meta-analysis has some strengths and limitations. The main strength is that the study includes all indices of incidence, mortality, and length of hospitalization of cancers in relation with a categorical and continuous score of DII. In addition, we carried out the meta-analysis on all types of cancer. The limitations of the study were as follows: (a) reviewed studies were heterogeneous in terms of population characteristics, design, and duration of follow-up periods; and (b) the questionnaires used for food assessment were different. However, we tried to reduce the effect of heterogeneity on estimated effect sizes by using a random-effect model of analysis.

Conclusions {#sec1-5}
===========

In conclusion, the present meta-analysis suggested a significant association between DII and incidence, mortality, and hospitalization in patients with different types of cancers. DII, which is used for evaluating inflammatory properties of diets, can be used as an appropriate tool to predict the incidence and mortality of all cancer types. According to the results of the study, we recommend that changing dietary patterns as malleable factors can substantially reduce both incidence and mortality risks in cancer patients.
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